Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$1.84 - $3.24 $41,433 - $72,958
22,518 New
22,518 $49,000
Q2 2021

Aug 05, 2021

SELL
$19.4 - $28.71 $176,753 - $261,576
-9,111 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$25.12 - $36.89 $24,517 - $36,004
-976 Reduced 9.68%
9,111 $256,000
Q4 2020

Feb 12, 2021

BUY
$24.2 - $35.76 $244,105 - $360,711
10,087 New
10,087 $262,000
Q2 2020

Aug 13, 2020

SELL
$30.04 - $51.31 $950,916 - $1.62 Million
-31,655 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$27.44 - $73.84 $25,875 - $69,631
943 Added 3.07%
31,655 $998,000
Q4 2019

Feb 12, 2020

SELL
$35.4 - $59.82 $1.7 Million - $2.88 Million
-48,133 Reduced 61.05%
30,712 $1.83 Million
Q3 2019

Nov 13, 2019

BUY
$34.47 - $47.53 $641,004 - $883,867
18,596 Added 30.87%
78,845 $2.89 Million
Q2 2019

Aug 14, 2019

BUY
$40.1 - $52.33 $2.42 Million - $3.15 Million
60,249 New
60,249 $2.8 Million
Q4 2018

Feb 13, 2019

SELL
$36.99 - $59.11 $1.94 Million - $3.11 Million
-52,544 Closed
0 $0
Q3 2018

Nov 02, 2018

BUY
$40.74 - $51.41 $968,349 - $1.22 Million
23,769 Added 82.6%
52,544 $2.33 Million
Q2 2018

Aug 08, 2018

SELL
$36.2 - $76.4 $1,339 - $2,826
-37 Reduced 0.13%
28,775 $1.13 Million
Q1 2018

May 03, 2018

BUY
$65.94 - $80.76 $293,103 - $358,978
4,445 Added 18.24%
28,812 $2.08 Million
Q4 2017

Feb 02, 2018

BUY
$43.47 - $67.43 $1.06 Million - $1.64 Million
24,367
24,367 $1.6 Million

Others Institutions Holding ESPR

About Esperion Therapeutics, Inc.


  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $112M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.